ESC Premium Access

Prognostic value of galectin-3 according to carbohydrate antigen 125 in transcatheter aortic valve implantation

Topic: Epidemiology, Prognosis, Outcome

Presentation

About the speaker

Doctor Tobias Andreas Rheude

German Heart Center of Munich, Munich (Germany)
0 follower

13 more presentations in this session

Psoas muscle area and volume and frailty scoring as predictors of outcomes after transcatheter aortic valve implantation

Speaker: Professor P. Kleczynski (Krakow, PL)

Thumbnail

Changes in valvulo-arterial impedance after transcatheter aortic valve implantation according to calcification burden of thoracic aorta

Speaker: Doctor T. Gegenava (Leiden, NL)

Thumbnail

Impact of serum hemoglobin level at discharge on long-term survival in patients undergoing transcatheter aortic valve implantation for severe aortic stenosis: an observational cohort study.

Speaker: Doctor M. Okamoto (Bernau bei Berlin, DE)

Thumbnail

Durability and clinical outcomes at 5 to 9 years following transcatheter aortic valve implantation

Speaker: Doctor A. Munoz Garcia (Malaga, ES)

Thumbnail

Impact of new onset atrial fibrillation on outcome of patients undergoing transfemoral transcatheter aortic valve replacement

Speaker: Mr R. Hoellriegel (Dresden, DE)

Thumbnail

Access the full session

Poster Session 5 - Deep dive in TAVI

Speakers: Doctor T. Rheude, Professor P. Kleczynski, Doctor T. Gegenava, Doctor M. Okamoto, Doctor A. Munoz Garcia...
Thumbnail

About the event

Image

ESC Congress 2018

25 August - 29 August 2018

Sessions Presentations

This platform is supported by

logo Novo Nordisk